ID   SCN3A_RAT               Reviewed;        1951 AA.
AC   P08104;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1988, sequence version 1.
DT   02-OCT-2024, entry version 185.
DE   RecName: Full=Sodium channel protein type 3 subunit alpha {ECO:0000305};
DE   AltName: Full=Sodium channel protein brain III subunit alpha;
DE   AltName: Full=Sodium channel protein type III subunit alpha;
DE   AltName: Full=Voltage-gated sodium channel subtype III;
DE   AltName: Full=Voltage-gated sodium channel subunit alpha Nav1.3;
GN   Name=Scn3a {ECO:0000312|RGD:3635};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar;
RX   PubMed=2449363; DOI=10.1016/0014-5793(88)80614-8;
RA   Kayano T., Noda M., Flockerzi V., Takahashi H., Numa S.;
RT   "Primary structure of rat brain sodium channel III deduced from the cDNA
RT   sequence.";
RL   FEBS Lett. 228:187-194(1988).
RN   [2]
RP   INTERACTION WITH SCORPION TOXIN BMK M1, AND MUTAGENESIS OF GLU-1559.
RX   PubMed=20678086; DOI=10.1042/bj20100517;
RA   He H., Liu Z., Dong B., Zhou J., Zhu H., Ji Y.;
RT   "Molecular determination of selectivity of the site 3 modulator (BmK I) to
RT   sodium channels in the CNS: a clue to the importance of Nav1.6 in BmK I-
RT   induced neuronal hyperexcitability.";
RL   Biochem. J. 431:289-298(2010).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-484; SER-485 AND SER-486, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [4]
RP   SUBUNIT, AND INTERACTION WITH THE CONOTOXIN GVIIJ.
RX   PubMed=24497506; DOI=10.1073/pnas.1324189111;
RA   Gajewiak J., Azam L., Imperial J., Walewska A., Green B.R.,
RA   Bandyopadhyay P.K., Raghuraman S., Ueberheide B., Bern M., Zhou H.M.,
RA   Minassian N.A., Hagan R.H., Flinspach M., Liu Y., Bulaj G., Wickenden A.D.,
RA   Olivera B.M., Yoshikami D., Zhang M.M.;
RT   "A disulfide tether stabilizes the block of sodium channels by the
RT   conotoxin muO[section sign]-GVIIJ.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:2758-2763(2014).
RN   [5]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBUNIT, INTERACTION WITH THE SPIDER
RP   RTX-VII TOXIN, AND MUTAGENESIS OF LYS-1503; TYR-1504; MET-1505; THR-1506;
RP   LEU-1507 AND GLU-1562.
RX   PubMed=25784299; DOI=10.1038/srep09241;
RA   Tang C., Zhou X., Zhang Y., Xiao Z., Hu Z., Zhang C., Huang Y., Chen B.,
RA   Liu Z., Liang S.;
RT   "Synergetic action of domain II and IV underlies persistent current
RT   generation in Nav1.3 as revealed by a tarantula toxin.";
RL   Sci. Rep. 5:9241-9241(2015).
RN   [6]
RP   SUBUNIT, INTERACTION WITH THE SPIDER BETA/DELTA-THERAPHOTOXIN-PRE1A, AND
RP   SITE SER-1510.
RX   PubMed=28428547; DOI=10.1038/s41598-017-01129-0;
RA   Wingerd J.S., Mozar C.A., Ussing C.A., Murali S.S., Chin Y.K.,
RA   Cristofori-Armstrong B., Durek T., Gilchrist J., Vaughan C.W., Bosmans F.,
RA   Adams D.J., Lewis R.J., Alewood P.F., Mobli M., Christie M.J., Rash L.D.;
RT   "The tarantula toxin beta/delta-TRTX-Pre1a highlights the importance of the
RT   S1-S2 voltage-sensor region for sodium channel subtype selectivity.";
RL   Sci. Rep. 7:974-988(2017).
CC   -!- FUNCTION: Pore-forming subunit of Nav1.3, a voltage-gated sodium (Nav)
CC       channel that directly mediates the depolarizing phase of action
CC       potentials in excitable membranes. Navs, also called VGSCs (voltage-
CC       gated sodium channels) or VDSCs (voltage-dependent sodium channels),
CC       operate by switching between closed and open conformations depending on
CC       the voltage difference across the membrane. In the open conformation
CC       they allow Na(+) ions to selectively pass through the pore, along their
CC       electrochemical gradient. The influx of Na+ ions provokes membrane
CC       depolarization, initiating the propagation of electrical signals
CC       throughout cells and tissues (PubMed:25784299). In some secretory cell
CC       types, it also participates in cell excitability through membrane
CC       depolarization and regulates cells responsiveness to stimuli triggering
CC       secretion. For instance, it controls the release of serotonin/5-
CC       hydroxytryptamine by enterochromaffin cells and is required for both
CC       glucagon- and glucose-induced insulin secretion in pancreatic endocrine
CC       cells (By similarity). {ECO:0000250|UniProtKB:A2ASI5,
CC       ECO:0000269|PubMed:25784299}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Na(+)(in) = Na(+)(out); Xref=Rhea:RHEA:34963,
CC         ChEBI:CHEBI:29101; Evidence={ECO:0000305|PubMed:25784299};
CC   -!- SUBUNIT: Heterooligomer of an alpha subunit, SCN3A, and 1 to 3
CC       regulatory beta subunits including SCN1B and SCN2B; disulfide-linked
CC       with some beta subunits like SCN2B. Interacts with NEDD4L; could
CC       regulate expression of SCN3A at the plasma membrane through
CC       ubiquitination-regulated endocytosis (By similarity). Interacts with
CC       the conotoxin GVIIJ (PubMed:24497506). Interacts with the spider
CC       beta/delta-theraphotoxin-Pre1a (PubMed:25784299, PubMed:28428547).
CC       Interacts with the spider RTX-VII toxin (AC P0DL75) (PubMed:25784299).
CC       {ECO:0000250|UniProtKB:Q9NY46, ECO:0000269|PubMed:24497506,
CC       ECO:0000269|PubMed:25784299, ECO:0000269|PubMed:28428547}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q9NY46};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:Q9NY46}. Basal cell
CC       membrane {ECO:0000250|UniProtKB:A2ASI5}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9NY46}. Note=In enterochromaffin cells,
CC       localized highly asymmetrically, almost exclusively at the basal side.
CC       {ECO:0000250|UniProtKB:A2ASI5}.
CC   -!- DOMAIN: The sequence contains 4 internal repeats, each with 5
CC       hydrophobic segments (S1, S2, S3, S5, S6) and one positively charged
CC       segment (S4). Segments S4 are probably the voltage-sensors and are
CC       characterized by a series of positively charged amino acids at every
CC       third position. {ECO:0000305}.
CC   -!- PTM: May be ubiquitinated by NEDD4L; which would promote its
CC       endocytosis. {ECO:0000250|UniProtKB:Q9NY46}.
CC   -!- PTM: Phosphorylation at Ser-1452 by PKC in a highly conserved
CC       cytoplasmic loop slows inactivation of the sodium channel and reduces
CC       peak sodium currents. {ECO:0000250|UniProtKB:Q14524}.
CC   -!- SIMILARITY: Belongs to the sodium channel (TC 1.A.1.10) family.
CC       Nav1.3/SCN3A subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y00766; CAA68735.1; -; mRNA.
DR   PIR; S00320; S00320.
DR   RefSeq; NP_037251.1; NM_013119.1.
DR   PDB; 1QG9; NMR; -; A=156-176.
DR   PDBsum; 1QG9; -.
DR   AlphaFoldDB; P08104; -.
DR   BMRB; P08104; -.
DR   SMR; P08104; -.
DR   BioGRID; 269080; 4.
DR   STRING; 10116.ENSRNOP00000006646; -.
DR   BindingDB; P08104; -.
DR   ChEMBL; CHEMBL4966; -.
DR   DrugCentral; P08104; -.
DR   GuidetoPHARMACOLOGY; 580; -.
DR   TCDB; 1.A.1.10.1; the voltage-gated ion channel (vic) superfamily.
DR   GlyCosmos; P08104; 8 sites, No reported glycans.
DR   GlyGen; P08104; 8 sites.
DR   iPTMnet; P08104; -.
DR   PhosphoSitePlus; P08104; -.
DR   SwissPalm; P08104; -.
DR   PaxDb; 10116-ENSRNOP00000006646; -.
DR   GeneID; 497770; -.
DR   KEGG; rno:497770; -.
DR   AGR; RGD:3635; -.
DR   CTD; 6328; -.
DR   RGD; 3635; Scn3a.
DR   eggNOG; KOG2301; Eukaryota.
DR   InParanoid; P08104; -.
DR   OrthoDB; 1110761at2759; -.
DR   PhylomeDB; P08104; -.
DR   EvolutionaryTrace; P08104; -.
DR   PRO; PR:P08104; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0016528; C:sarcoplasm; ISO:RGD.
DR   GO; GO:0001518; C:voltage-gated sodium channel complex; IDA:RGD.
DR   GO; GO:0005516; F:calmodulin binding; IDA:RGD.
DR   GO; GO:0031402; F:sodium ion binding; IDA:RGD.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; IDA:RGD.
DR   GO; GO:0048266; P:behavioral response to pain; ISO:RGD.
DR   GO; GO:0071236; P:cellular response to antibiotic; IDA:RGD.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0007399; P:nervous system development; IEP:RGD.
DR   GO; GO:0019228; P:neuronal action potential; IDA:RGD.
DR   GO; GO:0046684; P:response to pyrethroid; IDA:RGD.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IBA:GO_Central.
DR   CDD; cd13433; Na_channel_gate; 1.
DR   Gene3D; 1.10.287.70; -; 4.
DR   Gene3D; 1.10.238.10; EF-hand; 1.
DR   Gene3D; 1.20.5.1190; iswi atpase; 1.
DR   Gene3D; 1.20.120.350; Voltage-gated potassium channels. Chain C; 4.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR001696; Na_channel_asu.
DR   InterPro; IPR044564; Na_chnl_inactivation_gate.
DR   InterPro; IPR010526; Na_trans_assoc_dom.
DR   InterPro; IPR024583; Na_trans_cytopl.
DR   InterPro; IPR043203; VGCC_Ca_Na.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   PANTHER; PTHR10037:SF237; SODIUM CHANNEL PROTEIN TYPE 3 SUBUNIT ALPHA; 1.
DR   PANTHER; PTHR10037; VOLTAGE-GATED CATION CHANNEL CALCIUM AND SODIUM; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   Pfam; PF06512; Na_trans_assoc; 1.
DR   Pfam; PF11933; Na_trans_cytopl; 1.
DR   PRINTS; PR00170; NACHANNEL.
DR   SUPFAM; SSF81324; Voltage-gated potassium channels; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Phosphoprotein; Reference proteome; Repeat;
KW   Sodium; Sodium channel; Sodium transport; Transmembrane;
KW   Transmembrane helix; Transport; Ubl conjugation; Voltage-gated channel.
FT   CHAIN           1..1951
FT                   /note="Sodium channel protein type 3 subunit alpha"
FT                   /id="PRO_0000048494"
FT   TOPO_DOM        1..128
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        129..146
FT                   /note="Helical; Name=S1 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        147..152
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        153..174
FT                   /note="Helical; Name=S2 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        175..188
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        189..206
FT                   /note="Helical; Name=S3 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        207..213
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        214..235
FT                   /note="Helical; Name=S4 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        236..249
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        250..269
FT                   /note="Helical; Name=S5 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        270..369
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        370..386
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        387..397
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        398..424
FT                   /note="Helical; Name=S6 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        425..712
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        713..730
FT                   /note="Helical; Name=S1 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        731..738
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        739..763
FT                   /note="Helical; Name=S2 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        764..773
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        774..793
FT                   /note="Helical; Name=S3 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        794..797
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        798..816
FT                   /note="Helical; Name=S4 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        817..834
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        835..855
FT                   /note="Helical; Name=S5 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        856..880
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        881..896
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        897..907
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        908..934
FT                   /note="Helical; Name=S6 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        935..1156
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1157..1177
FT                   /note="Helical; Name=S1 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        1178..1189
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1190..1211
FT                   /note="Helical; Name=S2 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        1212..1217
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1218..1243
FT                   /note="Helical; Name=S3 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        1244..1252
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1253..1271
FT                   /note="Helical; Name=S4 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        1272..1284
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1285..1307
FT                   /note="Helical; Name=S5 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        1308..1353
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        1354..1370
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        1371..1393
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1394..1419
FT                   /note="Helical; Name=S6 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        1420..1477
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1478..1496
FT                   /note="Helical; Name=S1 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        1497..1504
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1505..1528
FT                   /note="Helical; Name=S2 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        1529..1538
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1539..1556
FT                   /note="Helical; Name=S3 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        1557..1568
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1569..1591
FT                   /note="Helical; Name=S4 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        1592..1604
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1605..1628
FT                   /note="Helical; Name=S5 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        1629..1650
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        1651..1663
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        1664..1695
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1696..1721
FT                   /note="Helical; Name=S6 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   TOPO_DOM        1722..1951
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REPEAT          110..455
FT                   /note="I"
FT                   /evidence="ECO:0000305"
FT   REPEAT          693..965
FT                   /note="II"
FT                   /evidence="ECO:0000305"
FT   REPEAT          1139..1450
FT                   /note="III"
FT                   /evidence="ECO:0000305"
FT   REPEAT          1459..1757
FT                   /note="IV"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          1851..1880
FT                   /note="IQ"
FT   REGION          28..60
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          493..529
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          587..633
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1068..1112
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1898..1951
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        28..53
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        497..511
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        512..529
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        587..616
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1902..1923
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1924..1951
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            1503
FT                   /note="Important residue that permits the spider RTX-VII
FT                   toxin to inhibit fast inactivation of the channel"
FT                   /evidence="ECO:0000269|PubMed:25784299"
FT   SITE            1506
FT                   /note="Important residue that permits the spider RTX-VII
FT                   toxin to inhibit fast inactivation of the channel"
FT                   /evidence="ECO:0000269|PubMed:25784299"
FT   SITE            1507
FT                   /note="Important residue that permits the spider RTX-VII
FT                   toxin to inhibit fast inactivation of the channel"
FT                   /evidence="ECO:0000269|PubMed:25784299"
FT   SITE            1510
FT                   /note="Key residue that permits the spider beta/delta-
FT                   theraphotoxin-Pre1a to inhibit fast inactivation of the
FT                   channel"
FT                   /evidence="ECO:0000269|PubMed:28428547"
FT   SITE            1562
FT                   /note="Important residue that permits the spider RTX-VII
FT                   toxin to inhibit fast inactivation of the channel"
FT                   /evidence="ECO:0000269|PubMed:25784299"
FT   MOD_RES         484
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         485
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         486
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1452
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000250|UniProtKB:Q14524"
FT   CARBOHYD        211
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        290
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        296
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        302
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        307
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        339
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1317
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1331
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        862
FT                   /note="Interchain; with SCN2B or SCN4B"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   DISULFID        862
FT                   /note="Interchain; with the conotoxin GVIIJ (when the
FT                   channel is not linked to SCN2B or SCN4B; the bond to SCN2B
FT                   or SCN4B protects the channel from the inhibition by
FT                   toxin)"
FT                   /evidence="ECO:0000250|UniProtKB:P04775"
FT   DISULFID        864..870
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   DISULFID        902..911
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   DISULFID        1315..1335
FT                   /evidence="ECO:0000250|UniProtKB:Q9NY46"
FT   MUTAGEN         1503
FT                   /note="K->P: 6-fold decrease in activity of the spider RTX-
FT                   VII toxin."
FT                   /evidence="ECO:0000269|PubMed:25784299"
FT   MUTAGEN         1504
FT                   /note="Y->E: 2-fold decrease in activity of the spider RTX-
FT                   VII toxin."
FT                   /evidence="ECO:0000269|PubMed:25784299"
FT   MUTAGEN         1505
FT                   /note="M->K: 4.5-fold decrease in activity of the spider
FT                   RTX-VII toxin."
FT                   /evidence="ECO:0000269|PubMed:25784299"
FT   MUTAGEN         1506
FT                   /note="T->I: 10-fold decrease in activity of the spider
FT                   RTX-VII toxin."
FT                   /evidence="ECO:0000269|PubMed:25784299"
FT   MUTAGEN         1507
FT                   /note="L->N: 12-fold decrease in activity of the spider
FT                   RTX-VII toxin."
FT                   /evidence="ECO:0000269|PubMed:25784299"
FT   MUTAGEN         1559
FT                   /note="E->D: Increase in sensitivity to the scorpion toxin
FT                   BMK M1."
FT                   /evidence="ECO:0000269|PubMed:20678086"
FT   MUTAGEN         1562
FT                   /note="E->Q: 5.5-fold decrease in activity of the spider
FT                   RTX-VII toxin."
FT                   /evidence="ECO:0000269|PubMed:25784299"
FT   MUTAGEN         1562
FT                   /note="E->R: 20-fold decrease in activity of the spider
FT                   RTX-VII toxin."
FT                   /evidence="ECO:0000269|PubMed:25784299"
FT   HELIX           161..174
FT                   /evidence="ECO:0007829|PDB:1QG9"
SQ   SEQUENCE   1951 AA;  221387 MW;  74E5E851524BD10E CRC64;
     MAQALLVPPG PESFRLFTRE SLAAIEKRAA EEKAKKPKKE QDIDDENKPK PNSDLEAGKN
     LPFIYGDIPP EMVSEPLEDL DPYYVSKKTF VVLNKGKAIF RFSATSALYI LTPLNPVRKI
     AIKILVHSLF SMLIMCTILT NCVFMTLSNP PDWTKNVEYT FTGIYTFESL IKILARGFCL
     EDFTFLRDPW NWLDFSVIVM AYVTEFVDLG NVSALRTFRV LRALKTISVI PGLKTIVGAL
     IQSVKKLSDV MILTVFCLSV FALIGLQLFM GNLRNKCSQW PPSDSAFETN TTSYFNGTMD
     SNGTFVNVTM STFNWKDYIA DDSHFYVLDG QKDPLLCGNG SDAGQCPEGY ICVKAGRNPN
     YGYTSFDTFS WAFLSLFRLM TQDYWENLYQ LTLRAAGKTY MIFFVLVIFL GSFYLVNLIL
     AVVAMAYEEQ NQATLEEAEQ KEAEFQQMLE QLKKQQEEAQ AVAAASAASR DFSGIGGLGE
     LLESSSEASK LSSKSAKEWR NRRKKRRQRE HLEGNHRADG DRFPKSESED SVKRRSFLLS
     LDGNPLTGDK KLCSPHQSLL SIRGSLFSPR RNSKTSIFSF RGRAKDVGSE NDFADDEHST
     FEDSESRRDS LFVPHRPGER RNSNGTTTET EVRKRRLSSY QISMEMLEDS SGRQRSMSIA
     SILTNTMEEL EESRQKCPPC WYRFANVFLI WDCCDAWLKV KHLVNLIVMD PFVDLAITIC
     IVLNTLFMAM EHYPMTQQFS SVLTVGNLVF TGIFTAEMVL KIIAMDPYYY FQEGWNIFDG
     IIVSLSLMEL GLANVEGLSV LRSFRLLRVF KLAKSWPTLN MLIKIIGNSV GALGNLTLVL
     AIIVFIFAVV GMQLFGKSYK ECVCKINVDC KLPRWHMNDF FHSFLIVFRV LCGEWIETMW
     DCMEVAGQTM CLIVFMLVMV IGNLVVLNLF LALLLSSFSS DNLAATDDDN EMNNLQIAVG
     RMQKGIDFVK NKIRECFRKA FFRKPKVIEI QEGNKIDSCM SNNTGIEISK ELNYLKDGNG
     TTSGVGTGSS VEKYVIDEND YMSFINNPSL TVTVPIAVGE SDFENLNTEE FSSESELEES
     KEKLNATSSS EGSTVDVAPP REGEQAEIEP EEDLKPEACF TEGCIKKFPF CQVSTEEGKG
     KIWWNLRKTC YSIVEHNWFE TFIVFMILLS SGALAFEDIY IEQRKTIKTM LEYADKVFTY
     IFILEMLLKW VAYGFQTYFT NAWCWLDFLI VDVSLVSLVA NALGYSELGA IKSLRTLRAL
     RPLRALSRFE GMRVVVNALV GAIPSIMNVL LVCLIFWLIF SIMGVNLFAG KFYHCVNTTT
     GNMFEIKEVN NFSDCQALGK QARWKNVKVN FDNVGAGYLA LLQVATFKGW MDIMYAAVDS
     RDVKLQPIYE ENLYMYLYFV IFIIFGSFFT LNLFIGVIID NFNQQKKKFG GQDIFMTEEQ
     KKYYNAMKKL GSKKPQKPIP RPANKFQGMV FDFVTRQVFD ISIMILICLN MVTMMVETDD
     QSKYMTLVLS RINLVFIVLF TGEFLLKLIS LRYYYFTIGW NIFDFVVVIL SIVGMFLAEL
     IEKYFVSPTL FRVIRLARIG RILRLIKGAK GIRTLLFALM MSLPALFNIG LLLFLVMFIY
     AIFGMSNFAY VKKEAGIDDM FNFETFGNSM ICLFQITTSA GWDGLLAPIL NSAPPDCDPD
     AIHPGSSVKG DCGNPSVGIF FFVSYIIISF LVVVNMYIAV ILENFSVATE ESAEPLSEDD
     FEMFYEVWEK FDPDATQFIE FCKLSDFAAA LDPPLLIAKP NKVQLIAMDL PMVSGDRIHC
     LDILFAFTKR VLGESGEMDA LRIQMEDRFM ASNPSKVSYE PITTTLKRKQ EEVSAAIIQR
     NYRCYLLKQR LKNISSKYDK ETIKGRIDLP IKGDMVIDKL NGNSTPEKTD GSSSTTSPPS
     YDSVTKPDKE KFEKDKPEKE IKGKEVRENQ K
//
